http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-2707017-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
filingDate 2012-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3eded024e4a8faaf147c93b78ef7d8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad9b558a502ee640b119e5aad7f5bf4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e232b788c9e4a6f9f5cd6154890b2871
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af2b239690cd15ccf84072a5693657e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7d4b48327265a7b1db5739b28f04870
publicationDate 2016-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-2707017-T3
titleOfInvention Lixisenatide and metformin for the treatment of type 2 diabetes
priorityDate 2011-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426284248
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90472060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091

Total number of triples: 26.